Covariate | Clinical pregnancya | Live birthb | ||
---|---|---|---|---|
OR (95% CI) | P | OR (95% CI) | P | |
Age | 0.92(0.90–0.94) | 0.000 | 0.91(0.89–0.93) | 0.000 |
PCOS | ||||
 YES | Reference |  | 1.00 |  |
 NO | 0.69(0.53–0.89) | 0.005 | 0.75(0.58–0.97) | 0.032 |
Endometriosis | ||||
 YES | 1.00 |  | 1.00 |  |
 NO | 1.83(1.01–3.33) | 0.045 | 1.53(0.81–2.89) | 0.181 |
Number of transferred embryos | 2.09(1.62–2.70) | 0.000 | 1.97(1.50–2.57) | 0.000 |
Grade of transferred embryos | Â | 0.000 | Â | 0.000 |
 Cleavage | 0.50(0.39–0.64) |  | 0.53(0.41–0.68) |  |
 Blastocyst | 1.00 |  | 1.00 |  |
Endometrial thickness | 1.09(1.02–1.16) | 0.011 | 1.07(1.00–1.15) | 0.04 |
Endometrial pattern | ||||
 Triple line | 1.38 (0.95–2.00) | 0.082 | 1.29(0.87–1.9) | 0.194 |
 No triple line | 1.00 |  | 1.00 |  |
Form of estrogen administration | Â | 0.570 | Â | 0.548 |
Without estrogen | 1.00 | Â | 1.00 | Â |
Estradiol gel | 0.67 (0.32–1.38) | 0.67 | 0.73 (0.35–1.52) | 0.408 |
Estradiol valerate | 0.66 (0.33–1.35) | 0.261 | 0.75 (0.36–1.54) | 0.44 |
Femoston | 0.74 (0.35–1.56) | 0.439 | 0.88 (0.41–1.87) | 0.746 |
Protocol | ||||
 With GnRha | 1.32(1.03–1.70) | 0.028 | 1.34(1.06–1.70) | 0.013 |
 Without GnRha | 1.00 |  | 1.00 |  |